Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,901 | 30,414 | 30,707 | 56,392 | 55,818 |
| Marketable Securities | 180,244 | 167,524 | 198,994 | 202,312 | 195,410 |
| Receivables | 11,686 | 12,454 | 12,330 | 9,160 | 7,227 |
| TOTAL | $228,742 | $218,515 | $250,729 | $277,615 | $266,001 |
| Non-Current Assets | |||||
| PPE Net | 23,285 | 22,550 | 23,319 | 18,669 | 14,829 |
| Investments And Advances | 20,699 | 68,775 | 64,279 | 60,006 | 74,615 |
| Other Non-Current Assets | 30,949 | 31,568 | 33,145 | 3,498 | 3,083 |
| TOTAL | $74,933 | $122,893 | $120,743 | $82,173 | $92,527 |
| Total Assets | $303,675 | $341,408 | $371,472 | $359,788 | $358,528 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,500 | 9,375 | 6,250 | 3,125 | N/A |
| Accounts payable and accrued liabilities | 10,705 | 6,009 | 11,173 | 7,642 | 5,891 |
| Accrued Expenses | 5,408 | 19,819 | 8,487 | 6,510 | 4,496 |
| Other current liabilities | 2,790 | N/A | 296 | 720 | 185 |
| TOTAL | $38,760 | $41,736 | $35,455 | $26,125 | $22,660 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,762 | 15,738 | 18,714 | 21,694 | 24,680 |
| Deferred Revenues | 6,279 | 5,496 | 7,804 | 8,128 | 12,088 |
| aiOther Non-Current Liabilities | 31,781 | 31,370 | 33,578 | 844 | 638 |
| TOTAL | $44,543 | $47,108 | $52,437 | $26,163 | $28,530 |
| Total Liabilities | $83,303 | $88,844 | $87,892 | $52,288 | $51,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,934 | 46,381 | 46,270 | 46,147 | 46,113 |
| Common Shares | 47 | 46 | 46 | 46 | 46 |
| Retained earnings | -372,521 | -333,411 | -295,286 | -264,384 | -258,232 |
| Other shareholders' equity | -1,152 | -314 | -30 | -45 | 0 |
| TOTAL | $220,372 | $252,564 | $283,580 | $307,500 | $307,338 |
| Total Liabilities And Equity | $303,675 | $341,408 | $371,472 | $359,788 | $358,528 |